# OnCo record ferabright-ferumoxytol (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ferabright-ferumoxytol/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ferabright-ferumoxytol" ;
  schema:name "Ferumoxytol for brain MRI (FeraBright)"@en ;
  schema:alternateName "FeraBright"@en, "ferumoxytol MRI contrast"@en, "FeraBright" ;
  schema:description "An iron-based MRI dye, not gadolinium, approved in the United States in 2025 for brain scans in adults with known or suspected brain tumours."@en ;
  schema:url <https://onco.cc/drugs/ferabright-ferumoxytol/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219868>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac666008-a14f-43b4-9d06-ec70f45a4234> ;
  onco:status "approved" ;
  onco:tag "contrast-agents-gaps-2026-11", "diagnostic" ;
  onco:modality "Iron-based contrast agent for MRI of the brain (intravenous)" ;
  onco:approval "US 2025: MRI of the brain in adults with known or suspected malignant neoplasms in the brain" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/secondary-brain-tumours/> ;
  onco:technologies <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/gadolinium-based-contrast-agents/> .